Effect of Rasburicase in renal function in children with acute kidney injury in Sheikh Children's Hospital

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2013091214637N1

Enrollment

Registered

2013-09-22

Start date

2013-09-21

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute kidney injury. Acute renal failure

Interventions

Amp rasburicase 0.2mg/kg QID With 50cc normal saline in 30 minutes.

Treatment - Drugs

Amp rasburicase 0.2mg/kg QID With 50cc normal saline in 30 minutes

Eligibility

Sex/Gender

All

Age

No minimum to 18 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: acute kidney injury with uric acid>14 with consent. Exclusion criteria: patients with chronic renal failure; AKI without hyperuricemia; G6PD disease.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Blood Urea and creatinine. Timepoint: First, thirth and seventh day. Method of measurement: Laboratory.	—

Secondary

Measure	Time frame
Disease resolved. Timepoint: First, third and seventh day. Method of measurement: Clinicl improvement and with lab.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAghilallah Keykhosravi

Mashhad Uinversity of Medical Sciences

keykhosrtavia901@mums.ac.ir+98 51 1868 3790

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026